Biontech Se ADR
(BNTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BNTX | RPRX | INCY | ||
| Company | Biontech Se ADR | Royalty Pharma Plc Cl A | Incyte Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 107.29 | 44.31 | 103.75 | ||
| High | 107.59 | 44.92 | 108.52 | ||
| Low | 105.81 | 43.95 | 103.52 | ||
| Latest | 106.62 | 44.65 | 108.39 | ||
| Change | +1.08 | +0.55 | +5.63 | ||
| % Change | +1.02% | +1.25% | +5.48% | ||
| Volume | 739,500 | 3,535,200 | 2,193,900 | ||
| 20-Day Average Volume | 1,063,285 | 3,911,105 | 1,771,805 | ||
| Previous Close | 105.54 | 44.10 | 102.76 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 110.68 | 41.08 | 103.70 | ||
| 20-Day Raw Stochastic | 30.84% | 95.47% | 98.05% | ||
| 20-Day Relative Strength | 50.65 | 74.53 | 58.99 | ||
| Weighted Alpha | -4.65 | +46.03 | +57.62 | ||
| Today's Opinion | 24% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 24% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 64% Sell | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.27% since 01/30/26 | +7.13% since 01/30/26 | +8.31% since 01/30/26 | ||
| Low | 105.42 on 02/05/26 | 41.46 on 02/02/26 | 99.50 on 02/02/26 | ||
| High | 111.36 on 02/02/26 | 44.92 on 02/06/26 | 108.52 on 02/06/26 | ||
| 1-Month | |||||
| %Chg | +8.70% since 01/06/26 | +9.84% since 01/06/26 | +1.62% since 01/06/26 | ||
| Low | 97.79 on 01/07/26 | 38.86 on 01/20/26 | 98.85 on 01/28/26 | ||
| High | 124.00 on 01/22/26 | 44.92 on 02/06/26 | 112.29 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +3.16% since 11/06/25 | +9.49% since 11/06/25 | +3.03% since 11/06/25 | ||
| Low | 91.11 on 12/18/25 | 37.31 on 11/24/25 | 93.54 on 12/12/25 | ||
| High | 124.00 on 01/22/26 | 44.92 on 02/06/26 | 112.29 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | -4.20% since 08/06/25 | +20.29% since 08/06/25 | +39.59% since 08/06/25 | ||
| Low | 90.12 on 09/12/25 | 34.08 on 09/08/25 | 76.79 on 08/07/25 | ||
| High | 124.00 on 01/22/26 | 44.92 on 02/06/26 | 112.29 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 24,008,904 | 25,773,678 | 21,279,448 | ||
| Shares Outstanding, K | 225,182 | 577,238 | 196,323 | ||
| Annual Sales | 2,976,970,000 | 2,263,580,000 | 4,241,220,000 | ||
| Annual Net Income | -719,920,000 | 858,980,000 | 32,610,000 | ||
| Last Quarter Sales | 1,775,440,000 | 609,290,000 | 1,365,980,000 | ||
| Last Quarter Net Income | -33,550,000 | 288,220,000 | 424,170,000 | ||
| 60-Month Beta | 1.49 | 0.42 | 0.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.14 on 11/03/25 | 1.17 on 11/05/25 | 2.26 on 10/28/25 | ||
| Latest Earnings Date | 03/09/26 | 02/11/26 | 02/10/26 | ||
| Most Recent Dividend | 3.084 on 06/02/22 | 0.220 on 11/14/25 | N/A | ||
| Next Ex-Dividends Date | 06/02/22 | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.76 | 19.32 | ||